GeneBio Systems

CGRP ELISA kit (Human)

Name: CGRP ELISA kit (Human)
Brand: GeneBio Systems
SKU: CEA876Hu
Price: 797.95 EUR
Availability: InStock

SKU:CEA876Hu

€797,95 EUR

Sale Sold out

Shipping calculated at checkout.

Quantity

Size: 96Tests

# of Times Cited in literature: 23

Prepare Time: 1-3 days(please inquire for mutiple units)

Target Name: CGRP

Target Full Name: Calcitonin Gene Related Peptide

Alternative Names: CALCB; CGRP2; CALC2; CGRP-II; Calcitonin Gene Related Peptide 2; Calcitonin 2; Calcitonin Related Polypeptide Beta

Target Species: Human

Uniprot: P10092

Gene ID: 797

Featured Series: CE kit

Featured Series Function: Detects small molecule

Specificity: Reactive with Human CGRP / Calcitonin Gene Related Peptide

Method: Colormetric

Detection principle: Competitive Inhibition

Detection range: 6.17-500pg/mL

Sensitivity: 2.23pg/mL

Assay Time: 2h

Sample Size: 50uL

Recommended/Predicted Sample Types: Serum, Plasma, Tissue Homogenates, Cell Lysates, Cell Culture Supernates and other Biological Fluids

Assay Precision: Intra-Assay: CV<10%, Inter-Assay: CV<12%

Reproducibility test menthod: Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Calcitonin Gene Related Peptide (CGRP) were tested 20 times on one plate, respectively. Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Calcitonin Gene Related Peptide (CGRP) were tested on 3 different plates, 8 replicates in each plate. CV(%) = SD/meanX100

Storage: 4°C for 1 month/ -20°C for long-term(One year within shelf life)

Shelf-life: 12 months

Specificity: This assay has high sensitivity and excellent specificity for detection of Calcitonin Gene Related Peptide (CGRP). No significant cross-reactivity or interference between Calcitonin Gene Related Peptide (CGRP) and analogues was observed.

Stability: The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition. To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Assay procedure summary: 1. Prepare all reagents, samples and standards; 2. Add 50µL standard or sample to each well. And then add 50µL prepared Detection Reagent A immediately. Shake and mix. Incubate 1 hour at 37°C; 3. Aspirate and wash 3 times; 4. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C; 5. Aspirate and wash 5 times; 6. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C; 7. Add 50µL Stop Solution. Read at 450 nm immediately.

Test principle: This assay employs the competitive inhibition enzyme immunoassay technique. A monoclonal antibody specific to Calcitonin Gene Related Peptide (CGRP) has been pre-coated onto a microplate. A competitive inhibition reaction is launched between biotin labeled Calcitonin Gene Related Peptide (CGRP) and unlabeled Calcitonin Gene Related Peptide (CGRP) (Standards or samples) with the pre-coated antibody specific to Calcitonin Gene Related Peptide (CGRP). After incubation the unbound conjugate is washed off. Next, avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. The amount of bound HRP conjugate is reverse proportional to the concentration of Calcitonin Gene Related Peptide (CGRP) in the sample. After addition of the substrate solution, the intensity of color developed is reverse proportional to the concentration of Calcitonin Gene Related Peptide (CGRP) in the sample.

Research Area: Infection immunity;Endocrinology;Neuro science;Hormone metabolism;Bone metabolism;Dermatology;

References Citing This Product: Alstonia scholaris R. Br. Significantly Inhibits Retinoid-Induced Skin Irritation In Vitro and In Vivo.

Increased levels of CGRP in peripheral blood in women with chronic migraine: A reliable biological marker

CGRP and VIP Levels as Predictors of Efficacy of Onabotulinumtoxin Type A in Chronic Migraine

Prognostic significance of circulating and endothelial progenitor cell markers in type 2 diabetic foot.

Calcitonin gene-and parathyroid hormone-related peptides in normotensive and preeclamptic pregnancies: a nested case–control study

OnabotulinumtoxinA decreases interictal CGRP plasma levels in patients with chronic migraine

Effect of acupuncture on house dust mite specific IgE, substance P, and symptoms in persistent allergic rhinitis

Relationship between serum levels of VIP, but not of CGRP, and cranial autonomic parasympathetic symptoms: A study in chronic migraine patients

Transient Receptor Potential Vanilloid Subtype 1 Inhibits Inflammation and Apoptosis via the Release of Calcitonin Gene-Related Peptide in the Heart after Myocardial Infarction.

Probiotic Bifidobacterium longum NCC3001 Reduces Depression Scores and Alters Brain Activity: A Pilot Study in Patients With Irritable Bowel Syndrome

Feasibility of serum CGRP measurement as a biomarker of chronic migraine: a critical reappraisal